Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Scientific Evidence, Regulatory Decision Making, and Incentives for Therapeutics in Infectious Diseases: The Example of Cefiderocol.

Literature DB >> 33257939

Scientific Evidence, Regulatory Decision Making, and Incentives for Therapeutics in Infectious Diseases: The Example of Cefiderocol.

John H Powers¹.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2021 PMID： 33257939 DOI： 10.1093/cid/ciaa1795

Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 9.079

Keyword Cloud
Cited

× No keyword cloud information.

3 in total

1. Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients.

Authors: Brian P Epling; John H Powers
Journal: Antimicrob Agents Chemother Date: 2022-07-18 Impact factor: 5.938

2. Cost Analysis of New Antibiotics to Treat Multidrug-Resistant Bacterial Infections: Mind the Gap.

Authors: Dafna Yahav; Daniel Shepshelovich; Noam Tau
Journal: Infect Dis Ther Date: 2021-02-13

Review 3. Iron-withdrawing anti-infectives for new host-directed therapies based on iron dependence, the Achilles' heel of antibiotic-resistant microbes.

Authors: Bruce E Holbein; M Trisha C Ang; David S Allan; Wangxue Chen; Christian Lehmann
Journal: Environ Chem Lett Date: 2021-04-23 Impact factor: 9.027

3 in total